AQST logo

Aquestive Therapeutics, Inc. (AQST) Operating Profit

Annual Operating Profit:

-$30.77M-$15.67M(-103.75%)
December 31, 2024

Summary

  • As of today, AQST annual operating income is -$30.77 million, with the most recent change of -$15.67 million (-103.75%) on December 31, 2024.
  • During the last 3 years, AQST annual operating profit has risen by +$3.91 million (+11.27%).
  • AQST annual operating profit is now -27130.97% below its all-time high of -$113.00 thousand, reached on December 31, 2017.

Performance

AQST Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAQSTincome statement metrics

Quarterly Operating Profit:

-$11.48M-$111.00K(-0.98%)
September 30, 2025

Summary

  • As of today, AQST quarterly operating income is -$11.48 million, with the most recent change of -$111.00 thousand (-0.98%) on September 30, 2025.
  • Over the past year, AQST quarterly operating profit has dropped by -$3.19 million (-38.47%).
  • AQST quarterly operating profit is now -210.15% below its all-time high of $10.42 million, reached on September 30, 2017.

Performance

AQST Quarterly Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAQSTincome statement metrics

TTM Operating Profit:

-$55.79M-$3.19M(-6.06%)
September 30, 2025

Summary

  • As of today, AQST TTM operating income is -$55.79 million, with the most recent change of -$3.19 million (-6.06%) on September 30, 2025.
  • Over the past year, AQST TTM operating profit has dropped by -$34.69 million (-164.37%).
  • AQST TTM operating profit is now -598.04% below its all-time high of $11.20 million, reached on September 30, 2017.

Performance

AQST TTM Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAQSTincome statement metrics

Operating Profit Formula

Operating Profit = Gross Profit − Operating Expenses

AQST Operating Profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-103.8%-38.5%-164.4%
3Y3 Years+11.3%-29.7%-29.7%
5Y5 Years+41.6%+16.7%-50.2%

AQST Operating Profit Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-103.8%+26.9%>-9999.0%+40.7%-269.4%at low
5Y5-Year-103.8%+41.6%>-9999.0%+40.7%-269.4%at low
All-TimeAll-Time>-9999.0%+41.6%-210.2%+64.9%-598.0%+17.1%

AQST Operating Profit History

DateAnnualQuarterlyTTM
Sep 2025
-
-$11.48M(-1.0%)
-$55.79M(-6.1%)
Jun 2025
-
-$11.37M(+41.3%)
-$52.60M(-27.7%)
Mar 2025
-
-$19.36M(-42.6%)
-$41.18M(-33.8%)
Dec 2024
-$30.77M(-103.8%)
-$13.58M(-63.8%)
-$30.77M(-45.8%)
Sep 2024
-
-$8.29M(>-9900.0%)
-$21.10M(-38.9%)
Jun 2024
-
$55.00K(+100.6%)
-$15.19M(+21.9%)
Mar 2024
-
-$8.96M(-129.0%)
-$19.45M(-28.8%)
Dec 2023
-$15.10M(+64.1%)
-$3.91M(-64.5%)
-$15.10M(+31.1%)
Sep 2023
-
-$2.38M(+43.5%)
-$21.90M(+22.8%)
Jun 2023
-
-$4.21M(+8.6%)
-$28.38M(+23.2%)
Mar 2023
-
-$4.61M(+57.0%)
-$36.93M(+12.2%)
Dec 2022
-$42.07M(-21.3%)
-$10.71M(-21.0%)
-$42.07M(+2.2%)
Sep 2022
-
-$8.85M(+30.6%)
-$43.02M(-2.1%)
Jun 2022
-
-$12.76M(-31.1%)
-$42.14M(-17.4%)
Mar 2022
-
-$9.74M(+16.5%)
-$35.89M(-3.5%)
Dec 2021
-$34.68M
-$11.67M(-46.4%)
-$34.68M(+10.3%)
Sep 2021
-
-$7.97M(-22.3%)
-$38.66M(+13.1%)
DateAnnualQuarterlyTTM
Jun 2021
-
-$6.52M(+23.6%)
-$44.47M(-18.4%)
Mar 2021
-
-$8.53M(+45.5%)
-$37.56M(+12.4%)
Dec 2020
-$42.89M(+18.6%)
-$15.65M(-13.5%)
-$42.89M(-15.5%)
Sep 2020
-
-$13.78M(-3588.9%)
-$37.15M(-8.1%)
Jun 2020
-
$395.00K(+102.8%)
-$34.37M(+35.7%)
Mar 2020
-
-$13.86M(-40.0%)
-$53.45M(-1.5%)
Dec 2019
-$52.67M(-7.6%)
-$9.90M(+10.0%)
-$52.67M(+4.4%)
Sep 2019
-
-$11.00M(+41.1%)
-$55.11M(-3.4%)
Jun 2019
-
-$18.69M(-42.9%)
-$53.31M(+20.8%)
Mar 2019
-
-$13.07M(-5.9%)
-$67.31M(-37.6%)
Dec 2018
-$48.94M(>-9900.0%)
-$12.35M(-34.2%)
-$48.93M(-11.6%)
Sep 2018
-
-$9.20M(+71.8%)
-$43.84M(-81.0%)
Jun 2018
-
-$32.69M(-716.1%)
-$24.22M(-385.9%)
Mar 2018
-
$5.30M(+173.1%)
$8.47M(+114.6%)
Dec 2017
-$113.00K(+86.7%)
-$7.26M(-169.6%)
$3.95M(-64.8%)
Sep 2017
-
$10.42M(+1234.3%)
$11.20M(+1334.3%)
Mar 2017
-
$781.00K
$781.00K
Dec 2016
-$847.00K
-
-

FAQ

  • What is Aquestive Therapeutics, Inc. annual operating income?
  • What is the all-time high annual operating profit for Aquestive Therapeutics, Inc.?
  • What is Aquestive Therapeutics, Inc. annual operating profit year-on-year change?
  • What is Aquestive Therapeutics, Inc. quarterly operating income?
  • What is the all-time high quarterly operating profit for Aquestive Therapeutics, Inc.?
  • What is Aquestive Therapeutics, Inc. quarterly operating profit year-on-year change?
  • What is Aquestive Therapeutics, Inc. TTM operating income?
  • What is the all-time high TTM operating profit for Aquestive Therapeutics, Inc.?
  • What is Aquestive Therapeutics, Inc. TTM operating profit year-on-year change?

What is Aquestive Therapeutics, Inc. annual operating income?

The current annual operating profit of AQST is -$30.77M

What is the all-time high annual operating profit for Aquestive Therapeutics, Inc.?

Aquestive Therapeutics, Inc. all-time high annual operating income is -$113.00K

What is Aquestive Therapeutics, Inc. annual operating profit year-on-year change?

Over the past year, AQST annual operating income has changed by -$15.67M (-103.75%)

What is Aquestive Therapeutics, Inc. quarterly operating income?

The current quarterly operating profit of AQST is -$11.48M

What is the all-time high quarterly operating profit for Aquestive Therapeutics, Inc.?

Aquestive Therapeutics, Inc. all-time high quarterly operating income is $10.42M

What is Aquestive Therapeutics, Inc. quarterly operating profit year-on-year change?

Over the past year, AQST quarterly operating income has changed by -$3.19M (-38.47%)

What is Aquestive Therapeutics, Inc. TTM operating income?

The current TTM operating profit of AQST is -$55.79M

What is the all-time high TTM operating profit for Aquestive Therapeutics, Inc.?

Aquestive Therapeutics, Inc. all-time high TTM operating income is $11.20M

What is Aquestive Therapeutics, Inc. TTM operating profit year-on-year change?

Over the past year, AQST TTM operating income has changed by -$34.69M (-164.37%)
On this page